Mankind Pharma Limited Stock: price and insider trades · India
Mankind Pharma Limited: what insiders have been doing
Every trade that managers of Mankind Pharma Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. Nothing new has been filed by managers of Mankind Pharma Limited in twelve months, the latest record being from 9 February 2024.
For comparison within the same sector, see the insider buying recorded at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Analyst consensus: bullish or bearish?
Analysts rate Mankind Pharma Limited Buy (bullish), based on 19 analysts. Average price target: ₹2,675.37.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,401,128 shares@ ₹2,107.35100.0% of flowEquity SharesSEBI:5dfdc9926a5136ebd831ba48ba9b5215b63b9ba2
- 1,817,070 shares@ ₹2,107.35100.0% of flowEquity SharesSEBI:858552ac34293912deed3b56e08766fd29f07d8a
- 2,271,336 shares@ ₹2,107.35100.0% of flowEquity SharesSEBI:e377e97546c56f6de9c6e03caa429cefc06b3f13
3 of 3 declarations
About Mankind Pharma Limited
Mankind Pharma Limited is an Indian company focused on the healthcare and pharmaceutical sector. It specializes in the research, development, and marketing of generic drugs and pharmaceutical products.
